344 related articles for article (PubMed ID: 35822939)
1. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease.
Islam R; Choudhary H; Rajan R; Vrionis F; Hanafy KA
J Cell Physiol; 2024 Jun; 239(6):e30829. PubMed ID: 35822939
[TBL] [Abstract][Full Text] [Related]
2. Zinc utilization by microglia in Alzheimer's disease.
Shippy DC; Oliai SF; Ulland TK
J Biol Chem; 2024 May; 300(5):107306. PubMed ID: 38648940
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in Alzheimer's may be associated with TLR4-LYN expression in damage associated microglia and neuronal phagocytosis.
Islam R; Rajan R; Choudhary H; Vrionis F; Hanafy KA
J Cell Physiol; 2024 Jun; 239(6):e30916. PubMed ID: 36409648
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
6. Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.
McQuade A; Blurton-Jones M
J Mol Biol; 2019 Apr; 431(9):1805-1817. PubMed ID: 30738892
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains.
Walker DG; Tang TM; Mendsaikhan A; Tooyama I; Serrano GE; Sue LI; Beach TG; Lue LF
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968618
[TBL] [Abstract][Full Text] [Related]
8. Microglia in Alzheimer's disease.
Hansen DV; Hanson JE; Sheng M
J Cell Biol; 2018 Feb; 217(2):459-472. PubMed ID: 29196460
[TBL] [Abstract][Full Text] [Related]
9. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
Qu W; Li L
Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
[TBL] [Abstract][Full Text] [Related]
10. Microglial phagocytosis in aging and Alzheimer's disease.
Gabandé-Rodríguez E; Keane L; Capasso M
J Neurosci Res; 2020 Feb; 98(2):284-298. PubMed ID: 30942936
[TBL] [Abstract][Full Text] [Related]
11. Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.
Wang M; Tang G; Zhou C; Guo H; Hu Z; Hu Q; Li G
Chem Biol Interact; 2023 Apr; 375():110387. PubMed ID: 36758888
[TBL] [Abstract][Full Text] [Related]
12. Microglial activation in Alzheimer's disease.
Schlachetzki JC; Hüll M
Curr Alzheimer Res; 2009 Dec; 6(6):554-63. PubMed ID: 19747160
[TBL] [Abstract][Full Text] [Related]
13. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
Martin E; Boucher C; Fontaine B; Delarasse C
Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
[TBL] [Abstract][Full Text] [Related]
14. Diabetic phenotype in mouse and humans reduces the number of microglia around β-amyloid plaques.
Natunen T; Martiskainen H; Marttinen M; Gabbouj S; Koivisto H; Kemppainen S; Kaipainen S; Takalo M; Svobodová H; Leppänen L; Kemiläinen B; Ryhänen S; Kuulasmaa T; Rahunen E; Juutinen S; Mäkinen P; Miettinen P; Rauramaa T; Pihlajamäki J; Haapasalo A; Leinonen V; Tanila H; Hiltunen M
Mol Neurodegener; 2020 Nov; 15(1):66. PubMed ID: 33168021
[TBL] [Abstract][Full Text] [Related]
15. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ
Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156
[TBL] [Abstract][Full Text] [Related]
16. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer's disease.
Ruganzu JB; Peng X; He Y; Wu X; Zheng Q; Ding B; Lin C; Guo H; Yang Z; Zhang X; Yang W
Mol Immunol; 2022 Feb; 142():22-36. PubMed ID: 34959070
[TBL] [Abstract][Full Text] [Related]
18. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
Spangenberg EE; Green KN
Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
20. IKK2/NF-κB Activation in Astrocytes Reduces amyloid β Deposition: A Process Associated with Specific Microglia Polarization.
Yang S; Magnutzki A; Alami NO; Lattke M; Hein TM; Scheller JS; Kröger C; Oswald F; Yilmazer-Hanke D; Wirth T; Baumann B
Cells; 2021 Oct; 10(10):. PubMed ID: 34685649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
